Thursday, May 10, 2012

Manejo del paciente con cardiopatía isquémica crónica y comorbilidades asociadas

Moderadores: Magda Heras - José Luis Lambert Rodríguez

Indicaciones actuales de:

• Tratamiento médico. Fernando Arós (Vitoria)
• Revascularización. Juan Sanchís (Valencia)
• Caso clínico. Francisco Calvo (Vigo)
• Caso clínico. Xavier Garcia-Moll (Barcelona) 

Opening Conference

Chaimen: José A. Barrabés - Pablo Avanzas

• Modifying risk factors does not always modify risk: how studies are changing our assumptions. Harlan Krumholz (New Haven, CT, US)

Friday, May 11, 2012

Round Table on CAD Pathophysiology and Prevention

Chairmen: Vicente Bodí - Xavier Bosch

• Understanding atherosclerosis disease in the present era. J. Wouter Jukema (Leiden, The Netherlands)
• Obstructive sleep apnea and cardiovascular disease. Bernard Gersh (Rochester, MN, US)
• Questions

Round Table: Update on NSTE-ACS

Chairmen: Héctor Bueno - Inmaculada Roldán

• What do biomarkers really add to NSTE-ACS diagnosis and management? Juan Carlos Kaski (London, UK)
• Invasive strategy in NSTE-ACS patients: for whom (if not for all), when, and how? Malcolm Bell (Rochester, MN, US)
• How to deal with the multichoice antithrombotic menu in NSTE-ACS? Dominick Angiolillo (Jacksonville, FL, US)

Round Table on Acute Cardiac Care

Chairmen: Javier Jiménez-Candil -  Rosa-Maria Lidón

• Mechanical circulatory support in cardiogenic shock: present and future. Pascal Vranckx (Hartcentrum, Hasselt, Belgium)
• Therapeutic hypothermia after cardiac arrest: indications and practical clues. Kjetil Sunde (Oslo, Norway) 
• Role of coronary revascularization and ICD in survivors of out-of-hospital cardiac arrest. Bernard Gersh (Rochester, MN, US)

Round Table on Diabetes and Coronary Artery Disease

Chairmen: Francisco Calvo - José M. de la Torre

• Primary prevention and pathophysiology of cardiovascular complications in diabetic patients. Peter Grant (Leeds, UK)
• Optimizing glycemic control in diabetics with unstable and stable coronary disease. Guntram Schernthaner (Vienna, Austria)
• Coronary revascularization in the diabetic patient. Laura Mauri (Boston, MA, US)

Saturday, May 12, 2012

Round Table on Advances in Coronary Revascularization

Chairmen: José Luis Pomar - Alberto San Román

• Role of imaging techniques in tailoring the indication and mode of revascularization. Frank Rademakers (Leuven, Belgium)
• The last innovations in PCI: devices and indications. Laura Mauri (Boston, MA, US)
• Advances in the surgical treatment of coronary artery disease. Robert A. Dion (Genk, Belgium)

Controversy: Genetic Tests and/or Platelet Function Studies Should Be Routinely Used to Guide Antiplatelet Therapy

Chairmen: Rosa-Maria Lidón - Inmaculada Roldán

• Pro: Dominick Angiolillo (Jacksonville, FL, US)
• Con: Marco Cattaneo (Milano, Italy)

Round Table: STEMI management in 2012

Chairmen: Vicente Bodí - Xavier Bosch

• Pharmaco-invasive reperfusion strategy: pros, cons, and optimal co-therapy. Malcolm Bell (Rochester, MN, US)
• How are we reperfusing our patients in real life? Lessons from the registries and targets for improvement. Harlan Krumholz (New Haven, CT, US)
• Is it possible to reduce reperfusion injury in patients with acute myocardial infarction? Derek Hausenloy (London, UK)

Closing Lecture

Chairman: Héctor Bueno

• Ischemic heart disease: what’s coming in 5 years? Valentín Fuster (New York, USA). Prince of Asturias Award for technical and scientific research